These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34239089)

  • 1. China at the threshold.
    Senior M
    Nat Biotechnol; 2021 Jul; 39(7):789-795. PubMed ID: 34239089
    [No Abstract]   [Full Text] [Related]  

  • 2. China spurs pharma innovation.
    Hughes B
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotechnology in Ireland: hard work, money and the brain gain.
    O'Neill MF
    Drug Discov Today; 2007 Feb; 12(3-4):108-11. PubMed ID: 17275730
    [No Abstract]   [Full Text] [Related]  

  • 4. China's biotech experiments.
    Hepeng J
    Nat Biotechnol; 2005 Dec; 23(12):1472-3. PubMed ID: 16421994
    [No Abstract]   [Full Text] [Related]  

  • 5. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 6. Sunbaked biotechnology in Australia.
    Littlejohn T
    Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech firms jump on SARS bandwagon.
    Basu P
    Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
    [No Abstract]   [Full Text] [Related]  

  • 8. The production capacity bottleneck.
    De Keyser JL
    Nat Biotechnol; 2001 Aug; 19(8):715. PubMed ID: 11479555
    [No Abstract]   [Full Text] [Related]  

  • 9. Built-to-buy start-ups begin to bloom.
    Mullard A
    Nat Rev Drug Discov; 2014 Mar; 13(3):161-2. PubMed ID: 24577386
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech at the beauty counter.
    Nasto B
    Nat Biotechnol; 2007 Jun; 25(6):617-9. PubMed ID: 17557090
    [No Abstract]   [Full Text] [Related]  

  • 11. Building for an exit (or not).
    Gunning TG
    Nat Biotechnol; 2008 Sep; 26(9):971-3. PubMed ID: 18792427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BioPartnering Europe--16th annual conference.
    Glah D; Bright J
    IDrugs; 2008 Dec; 11(12):880-3. PubMed ID: 19051148
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech meets the investors.
    Berry S
    Trends Biotechnol; 2002 Sep; 20(9):370-1. PubMed ID: 12175762
    [No Abstract]   [Full Text] [Related]  

  • 14. [Change the world through business partnering - commercialization of biotechnology and open-innovation].
    Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2013 May; 141(5):268-74. PubMed ID: 23665558
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 17. The commercialization of biotechnology in Japan.
    Müller C; Fujiwara T
    Drug Discov Today; 2002 Jul; 7(13):699-704. PubMed ID: 12110222
    [No Abstract]   [Full Text] [Related]  

  • 18. Any diamonds in the diagnostic coal?
    Jacobs T
    Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
    [No Abstract]   [Full Text] [Related]  

  • 19. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

  • 20. The stampede to convertibles.
    Jacobs T
    Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.